Vistin Pharma ASA ( ($DE:VP4) ) has issued an update. Vistin Pharma ASA reported a revenue increase in the third quarter of 2025, driven by a 10% ...

Deborah J. Wexler, MD, MSc, and colleagues reviewed recent shifts in diabetes care, such as SGLT2i and GLP-1 RA medications.

Sam Milby recently revealed his battle with latent autoimmune diabetes, which he said came as a surprise to him because he ...

HTD1801, a First-in-Class Anti-inflammatory Metabolic Modulator, Demonstrates Durable 52-Week Efficacy and Safety in Two Phase III Trials in Type 2 Diabetes Mellitus ...

Mrs. L, a 72-year-old woman with type 2 diabetes, had been taking metformin for the past 8 years to control her blood sugar. Recently, she began experiencing persistent fatigue and a tingling ...

Patients with asthma and T2 diabetes using SGLT2 inhibitors have a significantly decreased mortality risk within 30 days of an asthma exacerbation.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Could slightly elevated blood sugar levels lead to serious health problems in the future? A single patient's question sparked ...